This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
The Equity and Income Fund earned 0.2% in the quarter, while the Lipper Balanced Fund Index, the Fund’s performance benchmark, gained 1.1%.
PM C.WSA DOV.WI NOV TEL CVS FNF BAC C.WS.B CHTR APY.WI GM.WS.A FNFV C.WS.A GM.WS.B GM.WS.C C.PRP DOV C.PRU GM ORCL C.PRS LBRDB BAC C C.PRL AAL C.PRJ C.PRK BHGE COMM MA ARNC C.PRG TWC LBRDK C.PRC BHI C.PRPCL CGBBW OCLCF JLL LBRDA FL APY GM.WSB UNH
Foot Locker, Inc. (FL - Free Report) has managed to pull off a decent run in the past six months amid the prevailing headwinds in the retail sector. Shares of this company have gained nearly 13% in the past six months, notably outperforming the industry, which grew 9.5%. Also, this Zacks Rank #3 (Hold) stock has comfortably outpaced the broader Retail - Wholesale sector's growth of just 6.2% in the said time period.
SCVL CVRR FL URBN FOSL
One of the cheapest stocks in our Large Cap 1000 Stock Screener is Foot Locker Inc (FL).
Summer is here, and that means it’s time for barbecues and beach days, but also savings on some key services and retail products. Recently, smart shopping expert Trae Bodge of Slickdeals spoke to CNBC’s “On the Money” to share a few of the best deals that can be found this month.
[Call Started Abruptly] subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties are detailed in the reports filed with the SEC, including the Annual Report filed on Form 10-K.
When it comes to stock market coverage in the mainstream media, a select few hog the spotlight.
LZB JD SIG HUYA IRBT UAA NFLX ANF AMD RH NVDA PIR SKX WMT SFM AMZN NKE AAPL DKS BIDU AAXN AMC COST WTW FOSL SIG UA BABA MU IQ HEAR PLAY FL URBN FIVE
Nike (NKE - Free Report) is set to report its fourth-quarter and fiscal 2018 financial results after market close on Thursday. So let’s see if the sportswear power’s stock might be worth buying ahead of its earnings release and if Nike looks poised to rebound from its recent North American sales downturn.
NKE ADDYY RL FINL FL
The Nasdaq Composite, Nasdaq 100, small cap Russell 2000, Value Line Arithmetic and the NYSE Arca Biotechnology were among U.S. indices trading to all-time highs during Wednesday's session. In the real world, there is escalating risk of a destabilizing global trade war. The Shanghai Composite sank 4.4% this week to two-year lows. It was another week of instability for emerging market equities, bonds and currencies - especially in Asia.
LOW SYMC SIG AKRX KMX CHKVP UAA RL TWX CHKVZ SAM ASNA GM.WS.A TWTR GM.WS.B GM.WS.C CHK.PRD RCII CMCSK TWC FOSL NDAQ NTXFF CHK FL GM.WSB BA HBI CCV CONN NFLX AMD CCZ NTXFY CHKDH CHKDG FMCKI FMCKJ CHKDJ KR CHKDP BOE AAPL KSS SWN GM CKRGZ FMCCO FMCCP FMCCM FMCCN CMCSA TRIP FMCCI FMCCJ CVNA M FMCCG FMCKO NYTAB FMCKP FMCKM IWM FMCKN FMCKK FMCKL CHKWZ SIG W UA LHHMQ FMCC MU CCV.CL CHK.WI TSLA KN MNK GNW FIVE FMCCS FMCCT
14h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
15h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to FL / Foot Locker, Inc. on message board site Silicon Investor.
as of ET